Differences in the incidence of nosocomial-onset COVID-19 among hospitalized patients with exposure to SARS-CoV-2

Masataka Nakagawa; Yumiko Fujishiro; Yohei Doi; Junichi Yamakami; Hitoshi Honda

doi:10.1017/ice.2024.48

Differences in the incidence of nosocomial-onset COVID-19 among hospitalized patients with exposure to SARS-CoV-2

Infect Control Hosp Epidemiol. 2024 Mar 14:1-3. doi: 10.1017/ice.2024.48. Online ahead of print.

Authors

Masataka Nakagawa¹, Yumiko Fujishiro¹, Yohei Doi^{2

3}, Junichi Yamakami⁴, Hitoshi Honda^{1

2}

Affiliations

¹ Division of Infection Control, Department of Quality and Safety in Healthcare, Fujita Health University Hospital, Aichi, Japan.
² Department of Infectious Diseases, Fujita Health University School of Medicine, Aichi, Japan.
³ Division of Infectious Diseases, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
⁴ Department of Quality and Safety in Healthcare, Fujita Health University Hospital, Aichi, Japan.

PMID: 38482594
DOI: 10.1017/ice.2024.48

Abstract

We evaluated the secondary COVID-19 incidence among uninfected hospitalized patients after nosocomial COVID-19 exposure. An exposure source of SARS-CoV-2 was hospitalized patients or healthcare personnel (HCP) newly diagnosed as having COVID-19. Patients exposed to a COVID-19-infected patient in a shared room more frequently developed COVID-19 than those exposed to an infected HCP.